Comparison |
Alternate Manufacturer Number |
1725670 | | | 1630219 | |
Container Type |
Single-Use Vial | Single-Use Vial | Vial | Single-Use Vial | Vial |
Country of Origin |
Unknown | United States | Unknown | Unknown | Unknown |
Generic Drug Code |
90893 | 92809 | 02871 | 02939 | 02871 |
Generic Drug Name |
Poractant Alfa, Preservative Free | Calfactant | Beractant | Poractant Alfa, Preservative Free | Beractant |
NDC Number |
10122051003 | 61938045606 | 00074104004 | 10122051001 | 00074104008 |
Strength |
80 mg / mL | 35 mg / mL | 25 mg / mL | 80 mg / mL | 25 mg / mL |
UNSPSC Code |
51161709 | 51161710 | 51161702 | 51161709 | 51161702 |
Volume |
3 mL | 6 mL | 4 mL | 1.5 mL | 8 mL |
Application |
Pulmonary Surfactant | Pulmonary Surfactant | Pulmonary Surfactant | Pulmonary Surfactant | Pulmonary Surfactant |
Dosage Form |
Suspension | Suspension | Suspension | Suspension | Suspension |
Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Storage Requirements |
Requires Refrigeration | Requires Refrigeration | Requires Refrigeration | Requires Refrigeration | Requires Refrigeration |
Type |
Intratracheal | Intratracheal | Intratracheal | Intratracheal | Intratracheal |
Features and Benefits |
- Ready-to-use suspension
- CUROSURF® (poractant alfa) is intended for intratracheal use only
|
|
|
- CUROSURF is a surfactant indicated for the rescue treatment, including the reduction of mortality and pneumothoraces, of Respiratory Distress Syndrome (RDS) in premature infants
- CUROSURF® (poractant alfa) is intended for intratracheal use only
|
- SURVANTA is indicated for prevention and treatment (“rescue%XE2%X80?) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants
- Store refrigerated at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit)
|